pyramid pharma pharmaceuticals limited

4.5

pyramid pharma pharmaceuticals limited Company Information

Share PYRAMID PHARMA PHARMACEUTICALS LIMITED
Live 
MatureMidDeclining

Company Number

03844664

Registered Address

45 golders green road, london, NW11 8EL

Industry

Dispensing chemist in specialised stores

 

Telephone

02085202684

Next Accounts Due

January 2025

Group Structure

View All

Directors

Jagjeet Bhogal14 Years

Amir Bhogal0 Years

Shareholders

kabir singh bhogal 37.5%

amir bhogal 37.5%

View All

pyramid pharma pharmaceuticals limited Estimated Valuation

£1.8m

Pomanda estimates the enterprise value of PYRAMID PHARMA PHARMACEUTICALS LIMITED at £1.8m based on a Turnover of £7.6m and 0.24x industry multiple (adjusted for size and gross margin).

pyramid pharma pharmaceuticals limited Estimated Valuation

£1.8m

Pomanda estimates the enterprise value of PYRAMID PHARMA PHARMACEUTICALS LIMITED at £1.8m based on an EBITDA of £761.3k and a 2.39x industry multiple (adjusted for size and gross margin).

pyramid pharma pharmaceuticals limited Estimated Valuation

£12.7m

Pomanda estimates the enterprise value of PYRAMID PHARMA PHARMACEUTICALS LIMITED at £12.7m based on Net Assets of £6.2m and 2.03x industry multiple (adjusted for liquidity).

Valuation Calculator
This valuation is estimated based on financial data from April 2023 

Pyramid Pharma Pharmaceuticals Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Pyramid Pharma Pharmaceuticals Limited Overview

Pyramid Pharma Pharmaceuticals Limited is a live company located in london, NW11 8EL with a Companies House number of 03844664. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 1999, it's largest shareholder is kabir singh bhogal with a 37.5% stake. Pyramid Pharma Pharmaceuticals Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.6m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Pyramid Pharma Pharmaceuticals Limited Health Check

Pomanda's financial health check has awarded Pyramid Pharma Pharmaceuticals Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

3 Strong

positive_score

4 Regular

positive_score

5 Weak

size

Size

annual sales of £7.6m, make it smaller than the average company (£12.3m)

£7.6m - Pyramid Pharma Pharmaceuticals Limited

£12.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (4.6%)

-12% - Pyramid Pharma Pharmaceuticals Limited

4.6% - Industry AVG

production

Production

with a gross margin of 31.3%, this company has a comparable cost of product (31.3%)

31.3% - Pyramid Pharma Pharmaceuticals Limited

31.3% - Industry AVG

profitability

Profitability

an operating margin of 9.8% make it more profitable than the average company (2.7%)

9.8% - Pyramid Pharma Pharmaceuticals Limited

2.7% - Industry AVG

employees

Employees

with 98 employees, this is similar to the industry average (88)

98 - Pyramid Pharma Pharmaceuticals Limited

88 - Industry AVG

paystructure

Pay Structure

on an average salary of £22.1k, the company has an equivalent pay structure (£22.1k)

£22.1k - Pyramid Pharma Pharmaceuticals Limited

£22.1k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £77.8k, this is less efficient (£129k)

£77.8k - Pyramid Pharma Pharmaceuticals Limited

£129k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 31 days, this is near the average (31 days)

31 days - Pyramid Pharma Pharmaceuticals Limited

31 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 31 days, this is quicker than average (67 days)

31 days - Pyramid Pharma Pharmaceuticals Limited

67 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 50 days, this is more than average (30 days)

50 days - Pyramid Pharma Pharmaceuticals Limited

30 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 22 weeks, this is more cash available to meet short term requirements (18 weeks)

22 weeks - Pyramid Pharma Pharmaceuticals Limited

18 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 27.1%, this is a lower level of debt than the average (58.7%)

27.1% - Pyramid Pharma Pharmaceuticals Limited

58.7% - Industry AVG

pyramid pharma pharmaceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pyramid pharma pharmaceuticals limited. Get real-time insights into pyramid pharma pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Pyramid Pharma Pharmaceuticals Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for pyramid pharma pharmaceuticals limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

pyramid pharma pharmaceuticals limited Ownership

PYRAMID PHARMA PHARMACEUTICALS LIMITED group structure

Pyramid Pharma Pharmaceuticals Limited has 3 subsidiary companies.

Ultimate parent company

PYRAMID PHARMA PHARMACEUTICALS LIMITED

03844664

3 subsidiaries

PYRAMID PHARMA PHARMACEUTICALS LIMITED Shareholders

kabir singh bhogal 37.5%
amir bhogal 37.5%
jagjeet singh bhogal 25%

pyramid pharma pharmaceuticals limited directors

Pyramid Pharma Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Jagjeet Bhogal (Oct 2009) and Mr Amir Bhogal (Aug 2023).

officercountryagestartendrole
Mr Jagjeet BhogalUnited Kingdom59 years Oct 2009- Director
Mr Amir BhogalUnited Kingdom27 years Aug 2023- Director

PYRAMID PHARMA PHARMACEUTICALS LIMITED financials

EXPORTms excel logo

Pyramid Pharma Pharmaceuticals Limited's latest turnover from April 2023 is estimated at £7.6 million and the company has net assets of £6.2 million. According to their latest financial statements, Pyramid Pharma Pharmaceuticals Limited has 98 employees and maintains cash reserves of £389.8 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010Sep 2009
Turnover7,623,6155,812,07314,213,69811,143,3923,212,3343,937,8643,456,3514,476,4184,220,6143,457,7282,447,2731,821,6912,002,35300
Other Income Or Grants000000000000000
Cost Of Sales5,240,1744,185,5939,806,1327,839,6702,270,5692,731,3762,367,0063,064,2332,957,3822,395,1681,692,1031,286,3141,408,24100
Gross Profit2,383,4401,626,4804,407,5663,303,722941,7651,206,4891,089,3451,412,1841,263,2311,062,560755,170535,377594,11200
Admin Expenses1,638,3031,799,5103,238,2721,685,673-708,7301,062,488136,5451,005,8411,186,230577,700709,393507,750568,89600
Operating Profit745,137-173,0301,169,2941,618,0491,650,495144,001952,800406,34377,001484,86045,77727,62725,21600
Interest Payable67,068340,683015,78237,71733,23213,20000000000
Interest Receivable15,74166703142,3541,9781,0581412222100
Pre-Tax Profit693,809837,8971,169,2941,602,5801,615,131112,747940,658406,48477,004484,86245,77927,62925,21800
Tax-173,4520-222,166-304,490-306,875-21,422-178,725-81,297-15,401-101,821-10,529-6,631-6,55700
Profit After Tax520,357837,897947,1281,298,0901,308,25691,325761,933325,18761,603383,04135,25020,99818,66100
Dividends Paid000000000000000
Retained Profit520,357837,897947,1281,298,0901,308,25691,325761,933325,18761,603383,04135,25020,99818,66100
Employee Costs2,170,0342,020,944174,787173,414556,8321,114,021849,879778,430636,069513,343354,881235,552269,60800
Number Of Employees98969930614845373021141600
EBITDA*761,276-156,8911,169,2941,633,1351,665,582159,087958,447419,68085,034494,34658,42538,06535,78400

* Earnings Before Interest, Tax, Depreciation and Amortisation

Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010Sep 2009
Tangible Assets158,026174,1653,953,6243,321,641214,509229,596121,01796,114120,201124,56237,94531,31511,25000
Intangible Assets2,646,9462,174,474002,690,3563,443,2582,709,7792,007,1071,531,6361,528,0361,555,0001,105,000675,00000
Investments & Other0431,8620000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets2,804,9722,780,5013,953,6243,321,6412,904,8653,672,8542,830,7962,103,2211,651,8371,652,5981,592,9451,136,315686,25000
Stock & work in progress728,396751,39600496,812633,006492,387470,075468,584469,453441,360141,452151,20200
Trade Debtors655,173683,9423,094,9202,773,155478,133220,384242,505568,452451,260335,145140,202272,462259,96700
Group Debtors246,802246,80200131,147131,14764,89200000000
Misc Debtors3,745,5672,740,30900820,381350,199253,93200000000
Cash389,755350,99500627,163468790,76255,94146846846846846800
misc current assets000000000000000
total current assets5,765,6934,773,4443,094,9202,773,1552,553,6361,335,2041,844,4781,094,468920,312805,066582,030414,382411,63700
total assets8,570,6657,553,9457,048,5446,094,7965,458,5015,008,0584,675,2743,197,6892,572,1492,457,6642,174,9751,550,6971,097,88700
Bank overdraft126,779126,77900195,664141,54746,25900000000
Bank loan000000000000000
Trade Creditors 446,260257,334543,822524,74720,556575,107640,152812,976914,459845,251916,617420,069508,73600
Group/Directors Accounts000000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities317,585360,94500301,464459,302306,82400000000
total current liabilities890,624745,058543,822524,747517,6841,175,956993,235812,976914,459845,251916,617420,069508,73600
loans651,304403,78600321,786458,558376,14900000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities780,726677,4471,253,2501,265,705612,287675,056698,727539,483137,647153,973182,95990,479000
provisions000000000000000
total long term liabilities1,432,0301,081,2331,253,2501,265,705934,0731,133,6141,074,876539,483137,647153,973182,95990,479000
total liabilities2,322,6541,826,2911,797,0721,790,4521,451,7572,309,5702,068,1111,352,4591,052,106999,2241,099,576510,548508,73600
net assets6,248,0115,727,6545,251,4724,304,3444,006,7442,698,4882,607,1631,845,2301,520,0431,458,4401,075,3991,040,149589,15100
total shareholders funds6,248,0115,727,6545,251,4724,304,3444,006,7442,698,4882,607,1631,845,2301,520,0431,458,4401,075,3991,040,149589,15100
Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010Sep 2009
Operating Activities
Operating Profit745,137-173,0301,169,2941,618,0491,650,495144,001952,800406,34377,001484,86045,77727,62725,21600
Depreciation16,13916,139015,08615,08715,0865,64713,3378,0339,48612,64810,4383,75000
Amortisation0000000000006,81800
Tax-173,4520-222,166-304,490-306,875-21,422-178,725-81,297-15,401-101,821-10,529-6,631-6,55700
Stock-23,000751,3960-496,812-136,194140,61922,3121,491-86928,093299,908-9,750151,20200
Debtors976,489576,133321,7651,343,494727,931140,401-7,123117,192116,115194,943-132,26012,495259,96700
Creditors188,926-286,48819,075504,191-554,551-65,045-172,824-101,48369,208-71,366496,548-88,667508,73600
Accruals and Deferred Income-43,360360,9450-301,464-157,838152,478306,82400000000
Deferred Taxes & Provisions000000000000000
Cash flow from operations-220,099-1,409,963644,438684,69054,581-55,922898,533118,21723,59598,123376,796-59,978126,79400
Investing Activities
capital expenditure-472,4721,588,846-631,983-431,862752,902-857,144-733,222-464,721-7,272-69,139-469,278-460,503-696,81800
Change in Investments-431,862431,8620000000000000
cash flow from investments-40,6101,156,984-631,983-431,862752,902-857,144-733,222-464,721-7,272-69,139-469,278-460,503-696,81800
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000000000000
Other Short Term Loans 000000000000000
Long term loans247,518403,7860-321,786-136,77282,409376,14900000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities103,279-575,803-12,455653,418-62,769-23,671159,244401,836-16,326-28,98692,48090,479000
share issue0-361,7150-1,000,4900000000430,000570,49000
interest-51,327-340,0160-15,468-35,363-31,254-12,1421412222100
cash flow from financing299,470-873,748-12,455-684,326-234,90427,484523,251401,977-16,324-28,98492,482520,481570,49100
cash and cash equivalents
cash38,760350,9950-627,163626,695-790,294734,82155,473000046800
overdraft0126,7790-195,66454,11795,28846,25900000000
change in cash38,760224,2160-431,499572,578-885,582688,56255,473000046800

P&L

April 2023

turnover

7.6m

+31%

operating profit

745.1k

0%

gross margin

31.3%

+11.72%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

6.2m

+0.09%

total assets

8.6m

+0.13%

cash

389.8k

+0.11%

net assets

Total assets minus all liabilities

pyramid pharma pharmaceuticals limited company details

company number

03844664

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

September 1999

age

25

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

UK

address

45 golders green road, london, NW11 8EL

last accounts submitted

April 2023

pyramid pharma pharmaceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 16 charges/mortgages relating to pyramid pharma pharmaceuticals limited. Currently there are 10 open charges and 6 have been satisfied in the past.

charges

pyramid pharma pharmaceuticals limited Companies House Filings - See Documents

datedescriptionview/download